Atrás
89
54
Rango del Día
$907.23
$926.78
Rango de 52 Semanas
$623.78
$1,133.95
Volumen
2,127,912
Promedio 50D / 200D
$1,024.73
/
$892.56
Cierre Anterior
$906.70
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 41.7 | 0.4 |
| P/B | 32.4 | 2.9 |
| ROE % | 101.4 | 3.8 |
| Net Margin % | 31.7 | 3.9 |
| Rev Growth 5Y % | 23.2 | 10.0 |
| D/E | 1.6 | 0.2 |
Precio Objetivo de Analistas
Hold
$1,243.95
+36.6%
Low: $985.00
High: $1,350.00
P/E Futuro
26.5
EPS Futuro
$34.43
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
82 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$60.97
$56.29 – $66.45
|
130 B | 3 |
| FY2029 |
$55.40
$51.14 – $60.38
|
120 B | 3 |
| FY2028 |
$49.21
$42.81 – $55.86
|
110 B | 9 |
Puntos Clave
Revenue grew 23.17% annually over 5 years — strong growth
Earnings grew 94.88% over the past year
ROE of 101.35% indicates high profitability
Net margin of 31.66% shows strong profitability
Generating 8.97B in free cash flow
P/E of 41.68 — premium valuation
Crecimiento
Revenue Growth (5Y)
23.17%
Revenue (1Y)44.70%
Earnings (1Y)94.88%
FCF Growth (3Y)N/A
Calidad
Return on Equity
101.35%
ROIC32.26%
Net Margin31.66%
Op. Margin45.56%
Seguridad
Debt / Equity
1.60
Current Ratio1.58
Interest Coverage37.34
Valoración
P/E Ratio
41.68
P/B Ratio32.42
EV/EBITDA30.16
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 44.70% | Revenue Growth (3Y) | 38.20% |
| Earnings Growth (1Y) | 94.88% | Earnings Growth (3Y) | 98.45% |
| Revenue Growth (5Y) | 23.17% | Earnings Growth (5Y) | 38.67% |
| Profitability | |||
| Revenue (TTM) | 65.18B | Net Income (TTM) | 20.64B |
| ROE | 101.35% | ROA | 18.35% |
| Gross Margin | 83.79% | Operating Margin | 45.56% |
| Net Margin | 31.66% | Free Cash Flow (TTM) | 8.97B |
| ROIC | 32.26% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.60 | Current Ratio | 1.58 |
| Interest Coverage | 37.34 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 41.68 | P/B Ratio | 32.42 |
| P/S Ratio | 13.20 | PEG Ratio | 0.49 |
| EV/EBITDA | 30.16 | Dividend Yield | 0.01% |
| Market Cap | 860.30B | Enterprise Value | 895.64B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 65.18B | 45.04B | 34.12B | 28.54B | 28.32B |
| Net Income | 20.64B | 10.59B | 5.24B | 6.24B | 5.58B |
| EPS (Diluted) | 22.95 | 11.71 | 5.80 | 6.57 | 5.85 |
| Gross Profit | 54.62B | 36.62B | 27.04B | 21.91B | 21.01B |
| Operating Income | 29.70B | 17.50B | 10.79B | 8.65B | 7.93B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 112.48B | 78.71B | 64.01B | 49.49B | 48.81B |
| Total Liabilities | 85.94B | 64.44B | 53.14B | 38.71B | 39.65B |
| Shareholders' Equity | 26.54B | 14.19B | 10.77B | 10.65B | 8.98B |
| Total Debt | 42.50B | 33.64B | 25.23B | 16.24B | 16.88B |
| Cash & Equivalents | 7.16B | 3.27B | 2.82B | 2.07B | 3.82B |
| Current Assets | 55.63B | 32.74B | 25.73B | 18.03B | 18.45B |
| Current Liabilities | 35.23B | 28.38B | 27.29B | 17.14B | 15.05B |
Puntuaciones de Estrategias
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#13 of 154
Custom
Full Throttle
#43 of 146
Actividad Reciente
Entró
Growth Investing (Philip Fisher)
Mar 24, 2026
Entró
Full Throttle
Mar 24, 2026